Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
Respiratory viral illnesses are a well-established trigger of asthma exacerbations in children and adults1 and risk factor for poor outcomes and high health care utilization.2 Early studies from China identified chronic pulmonary disease as a risk factor3 for novel coronavirus disease 2019 (COVID-19) severity4 and death.5 US-based studies report that approximately 7% to 9% of hospitalized patients with COVID-19 had chronic lung disease,6,7 with asthma more prevalent than chronic obstructive pulmonary disease (COPD) (9% vs 5.4%, respectively).
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Liqin Wang, Dinah Foer, David W. Bates, Joshua A. Boyce, Li Zhou Tags: Letter to the Editor Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | China Health | Chronic Obstructive Pulmonary | Coronavirus | COVID-19 | Health Management | Intensive Care | Respiratory Medicine | Study